BARIUM SULFATE bulk active fine chemical sources

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek	⤷ Start Trial	24414	⤷ Start Trial
NovoSeek	⤷ Start Trial	517271	⤷ Start Trial
ABI Chem	⤷ Start Trial	AC1L2NF4	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: February 19, 2026

This report analyzes the global supply chain for bulk active pharmaceutical ingredient (API) barium sulfate. It identifies key manufacturing regions, major suppliers, regulatory considerations, and price drivers to inform procurement and R&D decisions.

What is Barium Sulfate and Its Pharmaceutical Applications?

Barium sulfate (BaSO₄) is an inorganic compound, a dense white powder, virtually insoluble in water and most solvents. Its radiopaque property, meaning it absorbs X-rays, makes it indispensable in medical imaging, primarily as a contrast agent for gastrointestinal (GI) tract examinations. It is administered orally or rectally to visualize the esophagus, stomach, small intestine, and colon during X-ray procedures like barium swallows, upper GI series, and barium enemas. Beyond diagnostics, purified barium sulfate finds niche applications in specialized pharmaceutical formulations.

Where is Bulk Barium Sulfate API Manufactured?

The global production of bulk barium sulfate API is concentrated in regions with established chemical manufacturing infrastructure, access to raw materials (barite ore), and adherence to stringent quality control standards.

China: Dominates global production volume. The country has extensive barite reserves and a mature chemical manufacturing sector, enabling large-scale, cost-competitive API production. Chinese manufacturers are significant exporters to markets worldwide.
India: A major player, leveraging its strong pharmaceutical API manufacturing base and skilled workforce. Indian producers focus on high-purity grades and compliance with international regulatory standards, catering to both domestic and export markets.
Europe: Several European countries, particularly Germany and Spain, maintain significant production capabilities. These manufacturers often focus on specialized, high-purity grades and are known for rigorous quality control and advanced manufacturing processes.
United States: While domestic production exists, it is generally on a smaller scale compared to Asian manufacturers. US-based facilities often cater to specific niche markets or serve as secondary suppliers, emphasizing domestic sourcing reliability.

Who are the Key Suppliers of Barium Sulfate API?

Multiple manufacturers supply bulk barium sulfate API, varying in scale, product specifications, and market focus. Key players include:

Asia (China & India):
- Hubei Xingfa Chemicals Group Co., Ltd. (China): A large-scale producer of phosphorus and fine chemical products, including high-purity barium sulfate.
- Zibo Nanshan Chemical Co., Ltd. (China): Specializes in inorganic salts and pigments, with barium sulfate as a core product.
- Shandong Baotong Chemical Co., Ltd. (China): Known for its production of various barium compounds, including pharmaceutical-grade barium sulfate.
- Navin Fluorine International Limited (India): While primarily known for fluorochemicals, it also has interests in inorganic salts and specialty chemicals.
- Aarti Industries Limited (India): A diversified chemical manufacturer with capabilities in inorganic specialty chemicals.
Europe:
- Sachtleben Chemie GmbH (Germany): A leading producer of titanium dioxide and functional additives, including high-purity barium sulfate for pharmaceutical applications.
- CASA DOPICO, S.A. (Spain): A historical producer of barytes and barium compounds, including pharmaceutical-grade barium sulfate.
United States:
- Celanese Corporation (USA): While a broad chemical company, it has a history of supplying various industrial and pharmaceutical ingredients.
- Piedmont Chemical Industries (USA): A specialty chemical manufacturer that may produce barium sulfate for specific market segments.

(Note: The supplier landscape is dynamic. Specific product availability, certifications, and manufacturing capacities should be verified directly with the companies.)

What are the Critical Quality Specifications for Pharmaceutical Barium Sulfate API?

Pharmaceutical-grade barium sulfate must meet stringent specifications to ensure patient safety and diagnostic efficacy. Key parameters include:

Purity: Typically >99.5% BaSO₄. Impurities like soluble barium salts, heavy metals (lead, arsenic, mercury), and other contaminants are strictly limited.
Particle Size Distribution: Crucial for suspension stability and ease of administration. Controlled particle size ensures uniform dispersion in liquid formulations and smooth passage through the GI tract. Micronized grades are common.
Insolubility: Minimum solubility of soluble barium compounds is a critical safety parameter, preventing systemic barium absorption.
Bulk Density & Tapped Density: Important for handling, storage, and formulation consistency.
Loss on Drying (LOD): Limits moisture content.
Sulphated Ash: Indicates inorganic impurity levels.
Microbiological Limits: Must comply with pharmacopoeial standards for bacterial endotoxins and microbial contamination.

Pharmacopoeial Standards: Barium sulfate API is tested against specifications outlined in major pharmacopoeias:

United States Pharmacopeia (USP):
- Assay: Not less than 98.0 percent and not more than 101.0 percent of BaSO₄.
- Limit of Soluble Salts: Not more than 50 mg per 100 g.
- Limit of Heavy Metals: Not more than 10 ppm.
- Limit of Arsenic: Not more than 2 ppm.
European Pharmacopoeia (Ph. Eur.):
- Assay: Not less than 98.0 percent and not more than 101.0 percent of BaSO₄.
- Limit of soluble barium compounds: Not more than 0.05 percent.
- Limit of heavy metals: Not more than 10 ppm.
- Limit of arsenic: Not more than 2 ppm.
Japanese Pharmacopoeia (JP): Similar stringent requirements for purity, heavy metals, and soluble barium.

What are the Regulatory Requirements for Barium Sulfate API Manufacturing?

Manufacturers of pharmaceutical-grade barium sulfate API must comply with a complex web of regulations to ensure product quality, safety, and efficacy.

Good Manufacturing Practices (GMP): All API manufacturing facilities must adhere to cGMP standards as defined by regulatory bodies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others. This covers facility design, equipment, personnel, production processes, quality control, and documentation.
Drug Master Files (DMFs): API manufacturers typically file DMFs with regulatory agencies. These confidential documents provide detailed information about the manufacturing process, quality control measures, and facility operations, which drug product manufacturers can reference in their marketing authorization applications.
Certifications: Manufacturers may hold certifications such as ISO 9001 (Quality Management Systems) and ISO 14001 (Environmental Management Systems).
Audits and Inspections: Facilities are subject to regular audits by regulatory authorities and customers to verify GMP compliance.
REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals): For companies exporting to the European Union, compliance with REACH regulations is necessary for the substance itself.

How is Barium Sulfate API Priced and What Drives Costs?

The pricing of bulk barium sulfate API is influenced by several factors:

Raw Material Costs (Barite Ore): The primary input is barite ore. Fluctuations in the mining and supply of high-purity barite directly impact production costs. Geographic availability and mining costs are key drivers.
Manufacturing Costs:
- Energy: Chemical processing, particularly purification and micronization, is energy-intensive.
- Labor: Skilled labor for quality control and process operation contributes to costs, especially in regions with higher labor rates.
- Chemicals: Reagents used in purification processes.
- Capital Investment: Maintaining GMP-compliant facilities and advanced processing equipment requires significant investment.
Purity and Grade: Higher purity grades and specialized particle size distributions command higher prices due to more intensive processing and quality control.
Regulatory Compliance: The cost associated with maintaining GMP certification, filing DMFs, and undergoing audits adds to the overall expense.
Supply and Demand: Global demand from the pharmaceutical sector and competition among suppliers influence market prices. Disruptions in supply chains (e.g., geopolitical issues, trade restrictions) can lead to price volatility.
Volume Commitments: Larger purchase volumes typically result in lower per-unit pricing.

General Price Range: The price for bulk pharmaceutical-grade barium sulfate API can range from approximately $2 to $10 per kilogram, depending on the factors listed above, particularly purity, supplier origin, and order volume. Micronized and exceptionally high-purity grades may be at the higher end of this range or exceed it.

What are the Future Trends in Barium Sulfate API Sourcing?

Increased Demand for High-Purity Grades: As diagnostic imaging techniques evolve and regulatory scrutiny intensifies, there is a continuous drive for barium sulfate APIs with exceptionally low impurity profiles and precisely controlled particle sizes.
Supply Chain Diversification: Companies are increasingly seeking to diversify their supplier base to mitigate risks associated with single-region dependence (e.g., geopolitical instability, trade policies). This may lead to renewed interest in non-Chinese manufacturing sources.
Technological Advancements: Innovations in purification and particle engineering technologies could lead to improved product characteristics and potentially more cost-effective production methods.
Sustainability Focus: Growing pressure for sustainable manufacturing practices may influence supplier selection, favoring those with robust environmental management systems and energy-efficient processes.
Consolidation and Specialization: The market may see consolidation among larger players or increased specialization by smaller manufacturers focusing on niche, high-value barium sulfate grades.

Key Takeaways

China is the dominant global producer of bulk barium sulfate API, followed by India and European manufacturers.
Key suppliers include Hubei Xingfa, Zibo Nanshan, Shandong Baotong (China); Aarti Industries, Navin Fluorine (India); Sachtleben Chemie (Germany); and CASA DOPICO (Spain).
Pharmaceutical-grade barium sulfate requires stringent purity, insoluble barium, and heavy metal specifications, meeting USP, Ph. Eur., and JP standards.
Compliance with GMP, DMF filing, and regulatory audits are critical for API manufacturers.
Pricing is driven by raw material (barite) costs, manufacturing complexity, purity requirements, regulatory overhead, and market supply/demand dynamics.
Future trends point towards increased demand for high-purity grades, supply chain diversification, and adoption of sustainable manufacturing.

Frequently Asked Questions

What is the primary risk associated with barium sulfate API sourcing?

The primary risk is the potential for supply chain disruptions stemming from geopolitical instability in key manufacturing regions, changes in trade policies, or unforeseen environmental regulations impacting barite mining or chemical processing.

How can a company verify the GMP compliance of a barium sulfate API supplier?

Verification involves reviewing the supplier's GMP certification, requesting access to recent audit reports (internal and external), conducting site audits (either in person or virtually), and ensuring the supplier maintains an up-to-date Drug Master File (DMF) with relevant regulatory agencies.

Are there alternative contrast agents to barium sulfate for GI imaging?

Yes, iodine-based contrast agents (e.g., iohexol, iopamidol) are widely used, particularly when bowel perforation is suspected or when CT imaging is required. Water-soluble contrast agents offer a different risk-benefit profile.

What is the typical lead time for ordering bulk barium sulfate API?

Lead times can vary significantly based on supplier inventory, production schedules, and shipping logistics. However, a typical lead time for a substantial order of bulk API can range from 4 to 12 weeks. This necessitates proactive inventory management and long-term procurement planning.

How does particle size distribution impact the efficacy of barium sulfate contrast media?

Particle size distribution is critical for creating stable suspensions. Larger particles can settle out, leading to inconsistent dosing and reduced imaging quality. Micronized particles ensure uniform dispersion, smooth passage through the GI tract, and optimal radiopacity for diagnostic clarity.

How do raw material price fluctuations affect the final API cost?

Barite ore is the primary raw material. Significant increases in barite mining costs, or disruptions in its availability due to environmental regulations or geopolitical factors, directly translate into higher production costs for barium sulfate API, often leading to increased API pricing.

Citations

[1] United States Pharmacopeia. (2023). United States Pharmacopeia and The National Formulary (USP-NF). [2] European Directorate for the Quality of Medicines & HealthCare. (n.d.). European Pharmacopoeia (Ph. Eur.). [3] Japanese Pharmacopoeial Convention. (2021). Japanese Pharmacopoeia. [4] U.S. Food and Drug Administration. (n.d.). Current Good Manufacturing Practice (cGMP) for Drugs. [5] European Medicines Agency. (n.d.). Good manufacturing practice.

Bulk Pharmaceutical API Sources for BARIUM SULFATE